The Food and Drug Administration (FDA) on Tuesday issued an emergency approval for a testing kit produced by Bodyshepere (an American company) that can detect coronavirus in two minutes.
Access to screening has improved in the U.S. but the average wait time for a patient’s results is four to five days — with some reports of it taking more than a week.
“Real-time tests are crucial because they will allow health officials to identify patients, isolate them and do “contact tracing” to locate people they interacted with,” said a health expert in US.
The FDA has been rushing to approve tests from companies that promise quicker results.
Bodysphere said it was working with the federal and state governments to deliver the test to the frontlines.
The test is administered like a glucose test but is designed for use strictly by medical professionals.